Cargando…
Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes
Heart failure, mostly associated with cardiac hypertrophy, is a major cause of illness and death. Oxidative stress causes accumulation of reactive oxygen species (ROS), leading to mitochondrial dysfunction, suggesting that mitochondria-targeted therapies could be effective in this context. The purpo...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029275/ https://www.ncbi.nlm.nih.gov/pubmed/35453408 http://dx.doi.org/10.3390/antiox11040723 |
_version_ | 1784691836273557504 |
---|---|
author | Peugnet, Victoriane Chwastyniak, Maggy Mulder, Paul Lancel, Steve Bultot, Laurent Fourny, Natacha Renguet, Edith Bugger, Heiko Beseme, Olivia Loyens, Anne Heyse, Wilfried Richard, Vincent Amouyel, Philippe Bertrand, Luc Pinet, Florence Dubois-Deruy, Emilie |
author_facet | Peugnet, Victoriane Chwastyniak, Maggy Mulder, Paul Lancel, Steve Bultot, Laurent Fourny, Natacha Renguet, Edith Bugger, Heiko Beseme, Olivia Loyens, Anne Heyse, Wilfried Richard, Vincent Amouyel, Philippe Bertrand, Luc Pinet, Florence Dubois-Deruy, Emilie |
author_sort | Peugnet, Victoriane |
collection | PubMed |
description | Heart failure, mostly associated with cardiac hypertrophy, is a major cause of illness and death. Oxidative stress causes accumulation of reactive oxygen species (ROS), leading to mitochondrial dysfunction, suggesting that mitochondria-targeted therapies could be effective in this context. The purpose of this work was to determine whether mitochondria-targeted therapies could improve cardiac hypertrophy induced by mitochondrial ROS. We used neonatal (NCMs) and adult (ACMs) rat cardiomyocytes hypertrophied by isoproterenol (Iso) to induce mitochondrial ROS. A decreased interaction between sirtuin 3 and superoxide dismutase 2 (SOD2) induced SOD2 acetylation on lysine 68 and inactivation, leading to mitochondrial oxidative stress and dysfunction and hypertrophy after 24 h of Iso treatment. To counteract these mechanisms, we evaluated the impact of the mitochondria-targeted antioxidant mitoquinone (MitoQ). MitoQ decreased mitochondrial ROS and hypertrophy in Iso-treated NCMs and ACMs but altered mitochondrial structure and function by decreasing mitochondrial respiration and mitophagy. The same decrease in mitophagy was found in human cardiomyocytes but not in fibroblasts, suggesting a cardiomyocyte-specific deleterious effect of MitoQ. Our data showed the importance of mitochondrial oxidative stress in the development of cardiomyocyte hypertrophy. We observed that targeting mitochondria by MitoQ in cardiomyocytes impaired the metabolism through defective mitophagy, leading to accumulation of deficient mitochondria. |
format | Online Article Text |
id | pubmed-9029275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90292752022-04-23 Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes Peugnet, Victoriane Chwastyniak, Maggy Mulder, Paul Lancel, Steve Bultot, Laurent Fourny, Natacha Renguet, Edith Bugger, Heiko Beseme, Olivia Loyens, Anne Heyse, Wilfried Richard, Vincent Amouyel, Philippe Bertrand, Luc Pinet, Florence Dubois-Deruy, Emilie Antioxidants (Basel) Article Heart failure, mostly associated with cardiac hypertrophy, is a major cause of illness and death. Oxidative stress causes accumulation of reactive oxygen species (ROS), leading to mitochondrial dysfunction, suggesting that mitochondria-targeted therapies could be effective in this context. The purpose of this work was to determine whether mitochondria-targeted therapies could improve cardiac hypertrophy induced by mitochondrial ROS. We used neonatal (NCMs) and adult (ACMs) rat cardiomyocytes hypertrophied by isoproterenol (Iso) to induce mitochondrial ROS. A decreased interaction between sirtuin 3 and superoxide dismutase 2 (SOD2) induced SOD2 acetylation on lysine 68 and inactivation, leading to mitochondrial oxidative stress and dysfunction and hypertrophy after 24 h of Iso treatment. To counteract these mechanisms, we evaluated the impact of the mitochondria-targeted antioxidant mitoquinone (MitoQ). MitoQ decreased mitochondrial ROS and hypertrophy in Iso-treated NCMs and ACMs but altered mitochondrial structure and function by decreasing mitochondrial respiration and mitophagy. The same decrease in mitophagy was found in human cardiomyocytes but not in fibroblasts, suggesting a cardiomyocyte-specific deleterious effect of MitoQ. Our data showed the importance of mitochondrial oxidative stress in the development of cardiomyocyte hypertrophy. We observed that targeting mitochondria by MitoQ in cardiomyocytes impaired the metabolism through defective mitophagy, leading to accumulation of deficient mitochondria. MDPI 2022-04-06 /pmc/articles/PMC9029275/ /pubmed/35453408 http://dx.doi.org/10.3390/antiox11040723 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Peugnet, Victoriane Chwastyniak, Maggy Mulder, Paul Lancel, Steve Bultot, Laurent Fourny, Natacha Renguet, Edith Bugger, Heiko Beseme, Olivia Loyens, Anne Heyse, Wilfried Richard, Vincent Amouyel, Philippe Bertrand, Luc Pinet, Florence Dubois-Deruy, Emilie Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title | Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title_full | Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title_fullStr | Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title_full_unstemmed | Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title_short | Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes |
title_sort | mitochondrial-targeted therapies require mitophagy to prevent oxidative stress induced by sod2 inactivation in hypertrophied cardiomyocytes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029275/ https://www.ncbi.nlm.nih.gov/pubmed/35453408 http://dx.doi.org/10.3390/antiox11040723 |
work_keys_str_mv | AT peugnetvictoriane mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT chwastyniakmaggy mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT mulderpaul mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT lancelsteve mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT bultotlaurent mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT fournynatacha mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT renguetedith mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT buggerheiko mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT besemeolivia mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT loyensanne mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT heysewilfried mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT richardvincent mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT amouyelphilippe mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT bertrandluc mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT pinetflorence mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes AT duboisderuyemilie mitochondrialtargetedtherapiesrequiremitophagytopreventoxidativestressinducedbysod2inactivationinhypertrophiedcardiomyocytes |